In summary, our findings identify Runx2 as a transcriptional activator of miR-23a and demonstrate that as an oncogene, miR-23a may promote lymphatic metastasis by targeting Mgat3, which regulates the branching pattern of N-glycans on the mouse hepatoma cell surface (Fig. 6). Here, RUNX2 is linked to hepatocellular carcinoma.